A 67-year-old man with acute anterolateral myocardial infarction had recurrent ventricular fibrillation that required insertion of temporary pacemaker. When a permanent pacemaker was inserted stable ...

Cardiac rhythm management is undergoing a significant shift. For decades, cardiac resynchronisation therapy has helped restore synchrony in patients with heart failure and electrical conduction ...

Pacing Clin Electrophysiol. 2008;31(2):229-231. A 52-year-old man was admitted in our institution with cranial traumatism due to a syn-copal episode that occurred while he was walking. Several weeks ...

AMSTERDAM, the Netherlands—In patients with sinus node dysfunction treated with dual-chamber pacemakers, minimizing atrial pacing doesn’t lower the likelihood of developing atrial fibrillation (AF) ...

Single-chamber ventricular leadless pacemakers do not support atrial pacing or consistent atrioventricular synchrony. A dual-chamber leadless pacemaker system consisting of two devices implanted ...

Minimizing atrial pacing does not alter the risk of atrial fibrillation (AF) associated with sinus node dysfunction (SND), suggest results of a trial that randomly assigned patients with SND who had ...

Minimizing atrial pacing does not prevent atrial fibrillation in patients with sinus node dysfunction, according to late-breaking research presented in a Hot Line session today at ESC Congress 2023.

AMSTERDAM -- Reducing atrial pacing didn't help prevent atrial fibrillation (Afib, or AF) in patients with sinus node dysfunction but did increase risk of fainting, the DANPACE II trial showed. The ...

When transvenous pacing is unsuitable, leadless cardiac pacemaker implantation can be used during the evidence generation period for dual-chamber pacing or right atrial pacing alone for ...

Patients requiring a pacemaker often have atrial fibrillation (AF), which increases the risk of thromboembolism and, consequently, the risk of morbidity and mortality. To maintain sinus rhythms, ...

An easy-to-do electrophysiological test, performed immediately after transcatheter aortic valve replacement (TAVR), could reliably rule out patients' future need for a pacemaker, researchers found.

The Aveir DR dual-chamber leadless pacemaker system (Abbott) performs well out to 1 year in patients largely treated for sinus node dysfunction or atrioventricular (AV) block, according to extended ...